Clinical Trials Logo

Chronic Pain clinical trials

View clinical trials related to Chronic Pain.

Filter by:

NCT ID: NCT05550506 Recruiting - Chronic Pain Clinical Trials

Duloxetine on Bone Metabolism

Start date: July 27, 2022
Phase:
Study type: Observational

The aim of the study was to determine the effect of duloxetine as monotherapy on biochemical markers and bone mineral density.

NCT ID: NCT05540002 Recruiting - Chronic Pain Clinical Trials

Efficacy of the Quell Wearable Device for Chronic Overlapping Pain Conditions

Start date: October 14, 2022
Phase: N/A
Study type: Interventional

This study will examine the pain-relieving effects of a transcutaneous electrical nerve stimulator device called a Quell for persons with multiple chronic overlapping pain conditions.

NCT ID: NCT05534126 Recruiting - Chronic Pain Clinical Trials

Enhancing Cognitive Processing Therapy for Posttraumatic Stress Disorder Via Stellate Ganglion Block Treatment: A Pilot Trial

SGB
Start date: November 1, 2022
Phase: N/A
Study type: Interventional

Cognitive Processing Therapy (CPT) is an effective first-line, evidence-based treatment for posttraumatic stress disorder (PTSD). Despite its well-demonstrated effectiveness, research has shown that approximately two-thirds of individuals continue to meet the diagnostic criteria for PTSD even after successful treatment completion. Stellate Ganglion Block (SGB) treatment, involving a local anesthesia injection to the stellate ganglion (around the lower base of the neck), has been shown to block its pain signal transmissions. Prior case studies and reviews have provided evidence for reducing PTSD symptoms with SGB treatment. However, studies to date have only examined SGB as a standalone intervention. The utility of combining CPT with concurrent SGB treatment remains unknown, although it is plausible that the combination of the two treatments can improve the effectiveness of CPT alone. The present study aims to test this hypothesis by comparing either a combined 1-week massed CPT + SGB treatment and 1-week massed CPT + placebo treatment (saline injection) using a randomized controlled trial design.

NCT ID: NCT05528536 Recruiting - Chronic Pain Clinical Trials

Acceptance and Commitment Therapy and Exercise for Older Adults With Chronic Pain

Start date: May 15, 2022
Phase: N/A
Study type: Interventional

The objective is to investigate on the effectiveness of Acceptance and Commitment Therapy and Exercise in: (Primary outcomes) 1. Increasing psychological flexibility 2. Reducing pain interference 3. Increasing quality of life 4. Increasing physical functioning (Secondary outcomes) 5. Reducing psychological distress - depression & anxiety

NCT ID: NCT05518630 Recruiting - Fibromyalgia Clinical Trials

An Investigation of Nomothetic Versus Idiographic Assessment in Chronic Pain

Start date: October 5, 2022
Phase:
Study type: Observational

Endometriosis, vulvodynia, and fibromyalgia are chronic pain conditions that cause great suffering. Despite the significant prevalence of all three conditions, they are receiving relatively little attention in psychological treatment research. Despite the popularity of methods that rely on aggregated group data, such as randomized controlled trials (RCTs), concerns have been raised in recent years about the generalizability of results from these methods to the individual level - group-to-individual generalizability. Since psychological treatments in the clinic are focused on enhancing the well-being of a specific individual this might affect how researchers should study these conditions. The current project aims to investigate: (a) item suitability for daily assessment of psychological variables, (b) group-to-individual generalizability in outcome measures frequently used in psychological studies and treatments of chronic pain, (c) relations over time between process and outcome variables, and (d) possible differences in results obtained across three pain conditions.

NCT ID: NCT05515341 Recruiting - Chronic Pain Clinical Trials

A DirEct to PatieNt Study in Chronic Pain

ENLITEN
Start date: January 10, 2023
Phase:
Study type: Observational

To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

NCT ID: NCT05513274 Recruiting - Clinical trials for Chronic Pain (Back / Neck)

Heartache and Backache- An Online Intervention Addressing Emotional and Physical Pain

Start date: December 15, 2022
Phase: N/A
Study type: Interventional

This study is designed to determine if a brief educational program and a written emotional disclosure task can improve chronic back/neck pain-related outcomes and change pain beliefs and other processes in individuals with chronic back pain. Individuals will be randomly assigned to an experimental condition (pain and affect neuroscience education) or a control condition (general health activities questionnaire), and then subsequently randomized to a second experimental condition (written emotional disclosure) or a control condition (writing about healthy habits). Analyses will examine the main and interactive effects of the pain and affect neuroscience education and written emotional disclosure on improved pain-related outcomes at 1-month follow-up. Participants in both the experimental conditions are expected to show more improvement on pain severity, pain interference, psychological distress and psychological attitudes toward pain at follow-up, relative to participants in the control groups.

NCT ID: NCT05512897 Recruiting - Chronic Pain Clinical Trials

Does ESP Block Reduce Pain and Opiates Consumption After Surgery

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

The patients will be randomly assigned to standard therapy or standard therapy+ESP nerve block. After surgery pain level and narcotic consumption will be measured, and vital signs and side effects will bo monitored for up to 72 hours. 6 months after surgery a phone interview will be conducted to asses chronic pain

NCT ID: NCT05509075 Recruiting - Pain, Acute Clinical Trials

Nutraceuticals and Functional Foods

Start date: November 12, 2019
Phase:
Study type: Observational

Supplements and functional foods are now readily available and usable by the general population. Many supplemnets are commonly used in poly-treated patients where interactions or adverse events may develop, therefore we evaluate in the rela life the use of nutraceuticals, their clinical effects and the development of adverse drug reactions

NCT ID: NCT05507034 Recruiting - Chronic Pain Clinical Trials

Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.

sCANsens
Start date: October 4, 2022
Phase:
Study type: Observational

Up to 40% of women experience chronic pain after treatment for breast cancer, and this pain is often very disabling. However, chronic pain after breast cancer remains under-recognised and undertreated. An effective and patient-tailored approach of (chronic) pain after breast cancer indeed requires a thorough knowledge and evaluation of the pain. In daily clinical practice, however, guidelines for a comprehensive diagnosis of pain in cancer patients and survivors are lacking. Further research in this topic is crucial for an efficient, preventive as well as curative, approach of pain after breast cancer. Besides the high prevalence and the important impact of pain in this population, the breast cancer population is also an ideal population to study chronic pain and its natural time course in different stages, since most patients start pain-free, but almost half of them end up with chronic pain. Therefore, this study aims to map biomarkers (both predictive, prognostic and diagnostic) for chronic pain after breast cancer treatment. We will study possible biopsychosocial biomarkers in relation to (chronic) pain and monitor their temporal changes from the moment of diagnosis until 1 year after surgery. The potential biomarkers are situated within the medical imaging of the brain, measurements of pain sensitivity and psychological variables.